Ocular Therapeutix (OCUL) FCF Margin Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 5,389.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1,525.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -341.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 43,511.00
10 Ocular Therapeutix 1.99 Bn 1.99 Bn 9.46 Mn -18,857.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -18,857.00
Dec 31, 2025 -11,799.00
Sep 30, 2025 -15,893.00
Jun 30, 2025 -26,430.00
Mar 31, 2025 -20,454.00
Dec 31, 2024 -11,730.00
Sep 30, 2024 -17,805.00
Jun 30, 2024 793.00
Mar 31, 2024 -7,692.00
Dec 31, 2023 2,970.00
Sep 30, 2023 5,901.00
Jun 30, 2023 -7,488.00
Mar 31, 2023 -1,103.00
Dec 31, 2022 -1,525.00
Sep 30, 2022 -61.00
Jun 30, 2022 8,272.00
Mar 31, 2022 9,343.00
Dec 31, 2021 -4,298.00
Sep 30, 2021 11,589.00
Jun 30, 2021 77,985.00
Mar 31, 2021 49,563.00
Dec 31, 2020 76,655.00
Sep 30, 2020 203,931.00
Jun 30, 2020 216,024.00
Mar 31, 2020 324,382.00
Dec 31, 2019 160,711.00
Sep 30, 2019 18,201.00
Jun 30, 2019 -126,848.00
Mar 31, 2019 -19,543.00
Dec 31, 2018 -28,090.00
Sep 30, 2018 11,871.00
Jun 30, 2018 61,068.00
Mar 31, 2018 -36,354.00
Dec 31, 2017 -55,533.00
Sep 30, 2017 -81,007.00
Jun 30, 2017 -21,284.00
Mar 31, 2017 -116,585.00
Dec 31, 2016 68,923.00
Sep 30, 2016 2.21 Mn
Jun 30, 2016 -19,201.00
Mar 31, 2016 78,787.00
Dec 31, 2015 -117,232.00
Sep 30, 2015 -1.94 Mn
Jun 30, 2015 238,647.00
Mar 31, 2015 1.30 Mn